4th Inflammatory Skin Disease Summit, The Translational Revolution

The field of Inflammatory Skin Disease is undergoing an evolution of translational research. Cutting edge research in Eczema, Psoriasis, Vitiligo, Alopecia Areata, and other skin conditions will be presented by international experts gathering in NYC on Nov. 3-6 at The New York Academy of Medicine, 1216 Fifth Avenue (at 103rd Street).

This is the first hybrid meeting since the pandemic with many live, in-person inflammatory skin disease experts attending and presenting their innovations. They will discuss new concepts and new developments in the field of inflammatory skin diseases and seek to devise and explore new therapeutic strategies. Successful bench-to-bedside collaborations have resulted in approval of many new therapies, with more on the way. 

Such leading experts as Drs. Emma Guttman-Yassky, and Patrick Brunner, Icahn School of Medicine, New York; Dr. James G. Krueger, Rockefeller University, New York; Dr. Kristian Reich, Dermatologikum, Berlin; and Dr. Amy S. Paller, Northwestern Medicine, Chicago will be presenting the latest innovations that result in proven therapies which advance patient care.